Concepedia

Author

Chengyuan Xue

Children's Cancer Institute Australia

Also Known As

Chengyuan Xue, Xue, Chengyuan

35

Publications

756

Citations

12

H-Index

41

Concepts

All Affiliations

Children's Cancer Institute AustraliaUNSW SydneyUniversity of BolognaSydney Children's HospitalGerman Cancer Research Center
CX

About

Chengyuan Xue is an author at Children's Cancer Institute Australia specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

255

2

Cell Biology

5

5

255

3

Engineering

1

1

22

4

Health Sciences

1

1

64

5

Biochemistry

1

1

22

Chengyuan Xue

×

9

Publications

536

Citations

9

H-Index

YearCitations

ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux

Michelle J. Henderson, Michelle Haber, Antônio Porro,

JNCI Journal of the National Cancer Institute

2011

124

Small-Molecule Multidrug Resistance–Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma

Catherine A. Burkhart, Fujiko Watt, Jayne Murray,

Cancer Research

2009

117

Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells

Antônio Porro, Michelle Haber, Daniel Diolaiti,

Journal of Biological Chemistry

2010

108

p53 Determines Multidrug Sensitivity of Childhood Neuroblastoma

Chengyuan Xue, Michelle Haber, Claudia L. Flemming,

Cancer Research

2007

64

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4

Chengyuan Xue, Denise Yu, Samuele Gherardi,

Oncotarget

2016

45

SimRE: Simple contrastive learning with soft logical rule for knowledge graph embedding

Dong Zhang, Zhe Rong, Chengyuan Xue,

Information Sciences

2024

22

Acteoside delays the fibrosis process of diabetic nephropathy by anti-oxidation and regulating the autophagy-lysosome pathway

Mengqi Zhou, Shujiao Zhang, Xuehui Bai,

European Journal of Pharmacology

2024

22

<i>MYCN</i>amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma

Diana Lau, Claudia L. Flemming, Samuele Gherardi,

Oncotarget

2015

18

Inhibition of mitochondrial translocase <scp>SLC25A5</scp> and histone deacetylation is an effective combination therapy in neuroblastoma

Janith A. Seneviratne, Daniel R. Carter, Rituparna Mittra,

International Journal of Cancer

2022

16

Page 1